Lipodystrophies Completed Phase 4 Trials for Lamivudine (DB00709)

Also known as: Lipodystrophy / Lipodystrophy NOS / Lipodystrophy acquired

IndicationStatusPhase
DBCOND0026618 (Lipodystrophies)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00006190A Study to Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop LipodystrophyDiagnostic
NCT00005764A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive PatientsTreatment
NCT00192621Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy SubjectsBasic Science
NCT00865007Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With LipoatrophyPrevention